Acrivon Therapeutics Inc. Common Stock is a cutting-edge pharmaceutical company focused on developing innovative therapeutics for cancer and autoimmune diseases. With a team of experienced scientists and state-of-the-art facilities, they are committed to making a significant impact on patient health by providing effective treatments for these complex diseases.
